NCT01599143 Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program Status COMPLETED Phase PHASE1
NCT01598610 Performance Evaluation of an Investigational Blood Glucose Monitoring System Status COMPLETED Phase NA
NCT01597713 A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0362 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01590836 A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01589653 Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Status COMPLETED Phase PHASE4
NCT01587599 Pharmaceutical Care of Patients With Impaired Mobility in a Model-region of Decreasing Supply of Medical Services Status UNKNOWN Phase PHASE4
NCT01585506 Psychosocial Factors Related to Compliance With Treatment With Biphasic Insulin Analogues Status COMPLETED Phase N/A
NCT01583790 Factors Influencing the Positive Outcome of Bariatric Surgery for Morbidly Obese Patients Status UNKNOWN Phase N/A
NCT01581073 PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease Status COMPLETED Phase PHASE3
NCT01575301 DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists Status COMPLETED Phase NA
NCT01575080 Performance Evaluation of Blood Glucose Monitoring System Using ISO Study Design Status COMPLETED Phase NA
NCT01573949 A Pilot Study: Metformin Therapy in Heart Failure Patients With Early Diabetes or at High Risk of Developing Diabetes (Pre-Diabetes) Status COMPLETED Phase NA
NCT01572753 Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01572740 Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01570751 A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin Status COMPLETED Phase PHASE3
NCT01569841 A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes Status COMPLETED Phase PHASE3